Table 1 Aconitase immunoreactivity of BPH glandular epithelumversus adenocarcinomatous glands of prostate cancer tissue sections.
From: Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues
| Â | TUMOR | ACONITASE IMMUNOREACTIVITY | ZIP1 IMMUNOREACTIVITY | ||
|---|---|---|---|---|---|
CASE # | GRADE | BPH | PCA | BPH | Malignant |
1 | 3 | +++ 8.9 | ++ 6.4 | ++ | Negative |
2 | 3 | + 6.4 | +++ 11.0 | ++ | + |
3 | 1 | + 6.2 | + 7.0 | + | Negative |
4 | 2 | +++ 14.6 | +++ 12.2 | + | Negative |
5 | 2 | ++ 12.6 | + 14.2 | Negative | Negative |
6 | 1 | +++ 12.2 | +++ 16.6 | ++ | Negative |
7 | 2 | ++ 10.0 | +++ 15.6 | + | + |
8 | 1 | +++ 11.4 | ++ 8.3 | ++ | + |
9 | 1 | + 7.5 | +++ 18.0 | ++ | Negative |
10 | 2 | + 8.4 | + 8.6 | ++ | Negative |
11 | 1 | + 12.6 | ++ 11.8 | ++ | Negative |
12 | 2 | + 9.7 | +++ 15.8 | Negative | Negative |
13 | 1 | +++ 13.7 | +++ 14.2 | ++ | + |
14 | 1 | +++ 13.9 | +++ 14.5 | + | Negative |
15 | 1 | + 7.6 | + 10.2 | + | Negative |
16 | 1 | ++ 11.6 | +++ 13.9 | + | Negative |
17 | 1 | ++ 14.2 | +++ 16.3 | ++ | + |
18 | 1 | ++ 9.2 | ++ 10.0 | + | Negative |
19 | 1 | +++ 12.0 | ++ 10.9 | + | Negative |
20 | 2 | +++ 14.7 | +++ 18.2 | ++ | + |
21 | 1 | +++ 14.1 | +++ 17.6 | Negative | Negative |
22 | 3 | +++ 16.3 | +++ 17.9 | ------------- | ------------- |
t-TEST- MEAN(SE) | Â | ||||
POSITIVITY | 2.1(0.85) | 2.4(0.94)** | 1.68(0.23) | 0.32(0.10)* | |
QUANTITATION | 11.3(2.9) | 13. 1(3.8)** | ------------- | ------------- | |